Teresa Mccarthy

CIK 1862121 · View on SEC EDGAR ↗

Insider

First SEC filing: May 20, 2021 · Latest: May 20, 2021

On this page

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 11 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Feb. 27, 2026 RNA D 50,000 — — 0 Direct -100.00% Disposed
Feb. 27, 2026 RNA D 78,000 — — 0 Direct -100.00% Disposed
Feb. 27, 2026 RNA D 54,000 — — 0 Direct -100.00% Disposed
Feb. 27, 2026 RNA D 108,000 — — 0 Direct -100.00% Disposed
Feb. 27, 2026 RNA D 57,500 — — 0 Direct -100.00% Disposed
Feb. 27, 2026 RNA D 65,000 — — 0 Direct -100.00% Disposed
Feb. 27, 2026 RNA D 106,000 — — 0 Direct -100.00% Disposed
Feb. 27, 2026 RNA D 165,296 — — 0 Direct -100.00% Disposed
Jan. 20, 2023 RNA A 108,000 — — 108,000 Direct — Acquired
Jan. 20, 2023 RNA A 20,000 — — 20,958 Direct +2087.68% Acquired
Jan. 21, 2022 RNA A 157,500 — — 157,500 Direct — Acquired

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (50,000) $31.42 Jan. 5, 2035 50,000 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (78,000) $10.16 Jan. 19, 2034 78,000 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (54,000) $6.57 Sept. 10, 2033 54,000 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (108,000) $22.47 Jan. 19, 2033 108,000 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (57,500) $14.22 Jan. 20, 2032 57,500 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (65,000) $22.34 Feb. 1, 2031 65,000 Disposed
Feb. 27, 2026 RNA Stock Option (Right to Buy) Common Stock (106,000) $29.00 Aug. 23, 2030 106,000 Disposed
Jan. 20, 2023 RNA Stock Option (Right to Buy) Common Stock (108,000) $22.47 Jan. 19, 2033 108,000 Acquired
Jan. 21, 2022 RNA Stock Option (Right to Buy) Common Stock (157,500) $14.22 Jan. 20, 2032 157,500 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
May 20, 2021 RNA Stock Option (Right to Buy)→ Common Stock (106,000) 106,000 Direct
May 20, 2021 RNA Stock Option (Right to Buy)→ Common Stock (110,000) 110,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CIK 1599901

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2024 $456,900 — $3,279,480 $560,843 $308,500 — $17,010 $4,622,733
2023 $439,300 — $3,097,607 — $175,720 — $13,766 $3,726,393
2022 $420,300 — — — $229,500 — $15,336 $2,265,809

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.